Evidence map›Paper›PMID 30777858›Full record

ArticleLife science alliance2019

MiR-146a wild-type 3' sequence identity is dispensable for proper innate immune function in vivo.

Grant Bertolet, Natee Kongchan, Rebekah Miller, Ravi K Patel, Antrix Jain, Jong Min Choi, Alexander B Saltzman, Amber Christenson, Sung Yun Jung, Anna Malovannaya and 2 more

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Grant BertoletGraduate Program in Immunology, Baylor College of Medicine, Houston, TX, USA.
Natee KongchanDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
Rebekah MillerDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Ravi K PatelDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Antrix JainMass Spectrometry Proteomics Core, Baylor College of Medicine, Houston, TX, USA.
Jong Min ChoiMass Spectrometry Proteomics Core, Baylor College of Medicine, Houston, TX, USA.
Alexander B SaltzmanVerna and Marrs McLean Department of Biochemistry and Molecular Biology, Baylor College of Medicine, Houston, TX, USA.
Amber ChristensonDepartment of Molecular Physiology and Biophysics, Baylor College of Medicine, Houston, TX, USA.
Sung Yun JungMass Spectrometry Proteomics Core, Baylor College of Medicine, Houston, TX, USA.
Anna MalovannayaMass Spectrometry Proteomics Core, Baylor College of Medicine, Houston, TX, USA.
Andrew GrimsonDepartment of Molecular Biology and Genetics, Cornell University, Ithaca, NY, USA.
Joel R NeilsonGraduate Program in Immunology, Baylor College of Medicine, Houston, TX, USA neilson@bcm.edu.ORCID 0000-0002-3408-608X
Baylor College of Medicine · USCornell University · US

Funding

Tumor BiologyP30CA125123 · NCI · BAYLOR COLLEGE OF MEDICINE · PI DAVID R ROWLEY · 2007 to 2026
$73.9M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI BUTEL, JANET S · 1994 to 2015
$21.7M
Hematology Training ProgramT32DK060445 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI GOODELL, MARGARET A. · 2002 to 2023
$8.3M
Small RNA Pathways in Mammalian GametogenesisP50HD076210 · NICHD · CORNELL UNIVERSITY · PI SCHLEGEL, PETER N · 2014 to 2018
$7.4M
Immunology Scientist Training ProgramT32AI053831 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI CORRY, DAVID B · 2003 to 2018
$4.2M
Translational control of EMT by the CELF1 RNA Binding ProteinR01CA190467 · NCI · BAYLOR COLLEGE OF MEDICINE · PI NEILSON, JOEL R · 2015 to 2021
$1.9M
BD Biosciences Special Order LSRIIS10RR024574 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI LUMPKIN, ELLEN A · 2009 to 2009
$430k
NCI NIH HHS P30 CA125123NCI NIH HHS R01 CA190467NCRR NIH HHS S10 RR024574NIAID NIH HHS P30 AI036211NIAID NIH HHS T32 AI053831NICHD NIH HHS P50 HD076210NIDDK NIH HHS T32 DK060445
6 · The paper itself

Abstract

The prevailing model of microRNA function is that the "seed region" (nt 2-8) is sufficient to mediate target recognition and repression. However, numerous recent studies have challenged this model, either by demonstrating extensive 3' pairing between physically defined miRNA-mRNA pairs or by showing in

Indexed as

3' Untranslated RegionsAllelesAnimalsFemaleGene Knockout TechniquesHeLa CellsHeterozygoteHomozygoteHumansImmunity, InnateKaplan-Meier EstimateMaleMiceMice, Inbred C57BLMice, KnockoutMicroRNAs3' Untranslated RegionsMicroRNAsMirn146 microRNA, mouseRNA, Messenger

Identifiers

PMID30777858
PMCPMC6379685
OpenAlexW2900831937

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.